Voyager Therapeutics, Inc.
VYGRFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Voyager Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 11, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Vestal Point Capital, LP | 2026-03-31 | 3,002,936 | $11.6M | SEC filing |
| Ikarian Capital, LLC | 2026-03-31 | 53,063 | $205K | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 78,891 | $305K | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 276,867 | $1.07M | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 228 | $910 | SEC filing |
| Brevan Howard Capital Management LP | 2026-03-31 | 11,365 | $43.9K | SEC filing |
| CIBC Asset Management Inc | 2026-03-31 | 11,335 | $43.8K | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 117,078 | Not shown | SEC filing |
| Stone House Investment Management, LLC | 2026-03-31 | 87 | $336 | SEC filing |
| SEI INVESTMENTS CO | 2026-03-31 | 28,937 | $112K | SEC filing |
| nVerses Capital, LLC | 2026-03-31 | 12,631 | $48.8K | SEC filing |
| Qube Research & Technologies Ltd | 2026-03-31 | 17,505 | $67.6K | SEC filing |
| ARMISTICE CAPITAL, LLC | 2026-03-31 | 3,500,000 | $13.5M | SEC filing |
| Persistent Asset Partners Ltd | 2026-03-31 | 107,094 | $413K | SEC filing |
| China Universal Asset Management Co., Ltd. | 2026-03-31 | 10,458 | $40.4K | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 582 | $2.25K | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 139,770 | $540K | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 3,347 | $12.9K | SEC filing |
| Hunter Perkins Capital Management, LLC | 2026-03-31 | 20,965 | Not shown | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 27,019 | $104K | SEC filing |
- Each value is checked against Voyager Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Voyager Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Voyager Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2023-02-01 · TEPPER ROBERT I: Larger than 89 of the 96 other insider sales of Common Stock on file. SEC filing
- 2023-01-31 · TEPPER ROBERT I: Larger than 92 of the 96 other insider sales of Common Stock on file. SEC filing
- 2023-01-11 · EcoR1 Capital, LLC: Larger than 87 of the 96 other insider sales of Common Stock on file. SEC filing
- 2023-01-10 · EcoR1 Capital, LLC: Larger than 94 of the 96 other insider sales of Common Stock on file. SEC filing
- 2023-01-09 · EcoR1 Capital, LLC: Larger than all 96 other insider sales of Common Stock on file. SEC filing
- 2022-08-25 · TEPPER ROBERT I: Larger than 93 of the 96 other insider sales of Common Stock on file. SEC filing
- 2022-08-24 · TEPPER ROBERT I: Larger than 91 of the 96 other insider sales of Common Stock on file. SEC filing
- 2022-08-16 · TEPPER ROBERT I: Larger than 88 of the 96 other insider sales of Common Stock on file. SEC filing
- 2022-08-15 · TEPPER ROBERT I: Larger than 90 of the 96 other insider sales of Common Stock on file. SEC filing
- 2022-08-12 · TEPPER ROBERT I: Larger than 95 of the 96 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-02 | Sandrock Alfred · President and CEO | Common Stock | S — Open market or private sale | −11,511 | 3.87 | SEC filing |
| 2026-02-24 | Sandrock Alfred · President and CEO | Common Stock | S — Open market or private sale | −14,197 | 3.79 | SEC filing |
| 2026-02-24 | Jorgensen Nathan D. · Chief Financial Officer | Common Stock | S — Open market or private sale | −4,668 | 3.77 | SEC filing |
| 2026-02-24 | Swartz Robin · COO & CBO | Common Stock | S — Open market or private sale | −6,458 | 3.77 | SEC filing |
| 2026-02-24 | Carter Todd Alfred · Chief Scientific Officer | Common Stock | S — Open market or private sale | −4,174 | 3.76 | SEC filing |
| 2026-02-18 | Swartz Robin · COO & CBO | Common Stock | S — Open market or private sale | −3,882 | 3.44 | SEC filing |
| 2026-02-18 | Carter Todd Alfred · Chief Scientific Officer | Common Stock | S — Open market or private sale | −3,301 | 3.44 | SEC filing |
| 2026-02-18 | Sandrock Alfred · President and CEO | Common Stock | S — Open market or private sale | −11,732 | 3.41 | SEC filing |
Showing 8 of 13 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-09 | GERAGHTY JAMES A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-09 | Onyia Jude · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-09 | Hyman Steven · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-09 | SCANGOS GEORGE A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-09 | Colon Grace · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-09 | PIERCE GLENN · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-09 | Vitale Nancy · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-09 | MACKEY CATHERINE J · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
Showing 8 of 14 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-02-02 | TEPPER ROBERT I · 10% owner | Common Stock | J — Other acquisition or disposition | −1,500,000 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.